Enzon extends rights agreement to March 18 and exchange offer to March 16

Viskase Holdings, Inc.

Ninth Amendment extends Section 382 Rights Agreement expiration to noon, March 18, 2026.
Exchange offer for Series C Preferred Stock extended to 5:00 p.m. Eastern, March 16, 2026.
Offer allows Series C Preferred holders to exchange shares for Enzon common stock.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Viskase Holdings, Inc. amended Ninth Amendment to the Section 382 Rights Agreement with Continental Stock Transfer & Trust Company valued at Extended the Final Expiration Date from noon, New York City time, on March 11, 2026 to noon, New Yor (effective 2026-03-10).

Action: amendment
Counterparty: Continental Stock Transfer & Trust Company
Value: Extended the Final Expiration Date from noon, New York City time, on March 11, 2026 to noon, New Yor
Effective: 2026-03-10

Exact text from the filing

On March 10, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Ninth Amendment to the Section 382 Rights Agreement (the “ Ninth Amendment ”), which amends the Section 382 Rights Agreement, dated as of August 14, 2020 (the “ Rights Agreement ”), by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.

View on SEC.gov

314 material agreements filed in the last 30 days. Browse all material agreements →

Viskase Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-026169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.